Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Uncovering the Potent Antiviral Activity of the Sesterterpenoids from the Sponge Ircinia Felix Against Human Adenoviruses: from the Natural Source to the Total Synthesis

  • Ruiz Molina, Ana María
  • Pech-Puch, Dawrin
  • Millán, Ramón
  • Ageitos, Lucía
  • Villegas-Hernández, Harold
  • Pachón, Jerónimo
  • Pérez Sestelo, José
  • Sánchez Céspedes, Javier
  • Rodríguez, Jaime
  • Jiménez, Carlos
Financiado para publicación en acceso aberto: Universidade da Coruña/CISUG., [Abstract] Human Adenovirus (HAdV) infections in immunocompromised patients can result in disseminated diseases with high morbidity and mortality rates due to the absence of available treatments for these infections. The sponge Ircinia felix was selected for the significant anti-HAdV activity displayed by its organic extracts. Its chemical analysis yielded three novel sesterterpene lactams, ircinialactams J−L, along with three known sesterterpene furans which structures were established by a deep spectrometric analysis. Ircinialactam J displayed significant antiviral activity against HAdV without significant cytotoxicity, showing an effectiveness 11 times greater than that of the standard treatment, cidofovir®. Comparison of the antiviral evaluation results of the isolated compounds allowed us to deduce some structure-activity relationships. Mechanistic assays suggest that ircinialactam J targets an early step of the HAdV replicative cycle before HAdV genome reaches the nucleus of the host cell. The first total synthesis of ircinialactam J was also accomplished to prove the structure and to provide access to analogues. Key steps are a regio- and stereoselective construction of the trisubstituted Z-olefin at Δ7 by iron-catalyzed carbometallation of a homopropargylic alcohol, a stereoselective methylation to generate the stereogenic center at C18, and the formation of the (Z)-Δ20 by stereoselective aldol condensation to introduce the tetronic acid unit. Ircinialactam J is a promising chemical lead to new potent antiviral drugs against HAdV infections., We gratefully acknowledge the help of colleagues, Daniel Catzim Pech, Carlos González-Salas, Gabriel González Mapen, Jorge Peniche Pérez, Melissa llanes López and Rodrigo Garcia Uribe for collecting the marine samples. We thank Patricia Gomez (ICMyL-UNAM) for helping with taxonomic identification. J.R. and C.J. acknowledge Xunta de Galicia and CESGA for the computational resources. Funding for open access charge: Universidade da Coruña/CISUG. This work was supported by grants PID2021-122732OB−C22 from MCIN/AEI/10.13039/ 501100011033/ FEDER “A way to make Europe” (AEI, Spanish State Agency for Research and FEDER Program from the European Union) and by Plan Nacional de I+D+i 2013–2016 and Instituto de Salud Carlos III, Proyectos de Desarrollo Tecnológico en Salud (DTS20/00010). Work in University of A Coruña was also supported by grant ED431 C 2022/39 from Xunta de Galicia. JS−C (CB21/13/00006) was supported by CIBERINFEC - Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU. J.S.C. is also supported by the program “Nicolás Monardes” (C-0059–2018) Servicio Andaluz de Salud, Junta de Andalucía. DP−P received a postdoctoral fellowship from the National Council of Humanities, Sciences and Technologies (CONAHCYT) of Mexico. L.A. thanks Xunta de Galicia (Spain) for a post-doctoral fellowship, ref: ED481B-2024-076, Xunta de Galicia; ED431 C 2022/39, Servicio Andaluz de Salud; C-0059–2018, Xunta de Galicia; ED481B-2024-076
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone

  • Balsera-Manzanero, María
  • Ghirga, Francesca
  • Ruiz-Molina, Ana
  • Mori, Mattia
  • Pachón, Jerónimo
  • Botta, Bruno
  • Cordero-Matía, Elisa
  • Quaglio, Deborah
  • Sánchez-Céspedes, Javier
© 2024 Balsera-Manzanero, Ghirga, Ruiz-Molina, Mori, Pachón, Botta, Cordero, Quaglio and Sánchez-Céspedes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms., Regardless of the clinical impact of human adenovirus (HAdV) infections in the healthy population and its high morbidity in immunosuppressed patients, a specific treatment is still not yet available. In this study, we screened the CM1407 COST Action’s chemical library, comprising 1,233 natural products to identify compounds that restrict HAdV infection. Among them, we identified rotenolone, a compound that significantly inhibited HAdV infection. Next, we selected four isoflavonoid-type compounds (e.g., rotenone, deguelin, millettone, and tephrosin), namely rotenoids, structurally related to rotenolone in order to evaluate and characterized in vitro their antiviral activities against HAdV and human cytomegalovirus (HCMV). Their IC50 values for HAdV ranged from 0.0039 µM for rotenone to 0.07 µM for tephrosin, with selective indices ranging from 164.1 for rotenone to 2,429.3 for deguelin. In addition, the inhibition of HCMV replication ranged from 50% to 92.1% at twice the IC50 concentrations obtained in the plaque assay for each compound against HAdV. Our results indicated that the mechanisms of action of rotenolone, deguelin, and tephrosin involve the late stages of the HAdV replication cycle. However, the antiviral mechanism of action of rotenone appears to involve the alteration of the microtubular polymerization, which prevents HAdV particles from reaching the nuclear membrane of the cell. These isoflavonoid-type compounds exert high antiviral activity against HAdV at nanomolar concentrations, and can be considered strong hit candidates for the development of a new class of broad-spectrum antiviral drugs., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was partially supported by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT). This work was partially supported by the Plan Nacional de I + D + i 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0009), cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative program Intelligent Growth 20142020, the Instituto de Salud Carlos III, Proyectos de Investigación en Salud (PI18/01191), and Proyectos de Desarrollo Tecnológico en Salud (DTS20/00010). JS-C and EC (CB21/13/00006) also were supported by CIBERINFEC—Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea–NextGenerationEU. JS-C is a researcher belonging to the program “Nicolás Monardes” (C-0059-2018), Servicio Andaluz de Salud, Junta de Andalucía, Spain., Peer reviewed